TY - JOUR
T1 - Glutathione suppresses cerebral infarct volume and cell death after ischemic injury
T2 - Involvement of FOXO3 inactivation and Bcl2 expression
AU - Song, Juhyun
AU - Park, Joohyun
AU - Oh, Yumi
AU - Lee, Jong Eun
N1 - Publisher Copyright:
© 2015 Juhyun Song et al.
PY - 2015
Y1 - 2015
N2 - Ischemic stroke interrupts the flow of blood to the brain and subsequently results in cerebral infarction and neuronal cell death, leading to severe pathophysiology. Glutathione (GSH) is an antioxidant with cellular protective functions, including reactive oxygen species (ROS) scavenging in the brain. In addition, GSH is involved in various cellular survival pathways in response to oxidative stress. In the present study, we examined whether GSH reduces cerebral infarct size after middle cerebral artery occlusion in vivo and the signaling mechanisms involved in the promotion of cell survival after GSH treatment under ischemia/reperfusion conditions in vitro. To determine whether GSH reduces the extent of cerebral infarction, cell death after ischemia, and reperfusion injury, we measured infarct size in ischemic brain tissue and the expression of claudin-5 associated with brain infarct formation. We also examined activation of the PI3K/Akt pathway, inactivation of FOXO3, and expression of Bcl2 to assess the role of GSH in promoting cell survival in response to ischemic injury. Based on our results, we suggest that GSH might improve the pathogenesis of ischemic stroke by attenuating cerebral infarction and cell death.
AB - Ischemic stroke interrupts the flow of blood to the brain and subsequently results in cerebral infarction and neuronal cell death, leading to severe pathophysiology. Glutathione (GSH) is an antioxidant with cellular protective functions, including reactive oxygen species (ROS) scavenging in the brain. In addition, GSH is involved in various cellular survival pathways in response to oxidative stress. In the present study, we examined whether GSH reduces cerebral infarct size after middle cerebral artery occlusion in vivo and the signaling mechanisms involved in the promotion of cell survival after GSH treatment under ischemia/reperfusion conditions in vitro. To determine whether GSH reduces the extent of cerebral infarction, cell death after ischemia, and reperfusion injury, we measured infarct size in ischemic brain tissue and the expression of claudin-5 associated with brain infarct formation. We also examined activation of the PI3K/Akt pathway, inactivation of FOXO3, and expression of Bcl2 to assess the role of GSH in promoting cell survival in response to ischemic injury. Based on our results, we suggest that GSH might improve the pathogenesis of ischemic stroke by attenuating cerebral infarction and cell death.
UR - http://www.scopus.com/inward/record.url?scp=84923875879&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84923875879&partnerID=8YFLogxK
U2 - 10.1155/2015/426069
DO - 10.1155/2015/426069
M3 - Article
C2 - 25722793
AN - SCOPUS:84923875879
SN - 1942-0900
VL - 2015
JO - Oxidative medicine and cellular longevity
JF - Oxidative medicine and cellular longevity
M1 - 426069
ER -